发明授权
- 专利标题： Fn14/TRAIL fusion proteins
- 专利标题（中）： Fn14 / TRAIL融合蛋白
-
申请号： US12494680申请日： 2009-06-30
-
公开(公告)号： US08039437B2公开(公告)日： 2011-10-18
- 发明人: Mark L. Tykocinski , Marjaneh Razmara
- 申请人： Mark L. Tykocinski , Marjaneh Razmara
- 申请人地址： US PA Philadelphia
- 专利权人： The Trustees of the University of Pennsylvania
- 当前专利权人： The Trustees of the University of Pennsylvania
- 当前专利权人地址： US PA Philadelphia
- 代理机构： Riverside Law LLP
- 主分类号： A61K38/16
- IPC分类号： A61K38/16 ; C07K14/715 ; C07K14/52 ; C12N15/00
摘要：
Fusion proteins which act on the TWEAK and TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, as well as other diseases such as alloimmune diseases and cancer.
公开/授权文献
- US20100048478A1 FN14/TRAIL FUSION PROTEINS 公开/授权日：2010-02-25
信息查询
IPC分类:
